Jad Chahoud, Chief Scientific and Innovation Officer at Orlando Health Cancer Institute, shared a post on LinkedIn:
“Truly enjoyed the outstanding talk today by Amy Laughlin Orlando Health ASCO26 covering Excellence in patient centered care from Home care to outpatient CAR-T therapy and E-Sym role in phase 1 trial patients.”
Other articles featuring Jad Chahoud on OncoDaily.